![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1403393
¼¼°èÀÇ ±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç°, µµ±¸, ±â¼ú, ¿ëµµ ¹× Áö¿ªº° ¼¼°è ºÐ¼®Structural Biology & Molecular Modeling Market Forecasts to 2030 - Global Analysis By Product, Tools (Software as a Service & Standalone Modeling, Visualization & Analysis, Databases and Other Tools), Technology, Application and By Geography |
Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ½ÃÀåÀº 2023³â 49¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 18.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 158¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ±â¼úÀº ¼·Î ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ´Â µÎ ºÐ¾ß·Î, »ýü °íºÐÀÚÀÇ ±¸Á¶¿Í ±â´ÉÀ» ºÐÀÚ ¼öÁØ¿¡¼ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ±â¼úÀº ±âÃÊ ¿¬±¸ºÎÅÍ ÀÇ·á, ³ó¾÷, »ê¾÷ ºÐ¾ßÀÇ ½Ç¿ëÀûÀÎ ÀÀ¿ë¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëÇÒ ¼ö ÀÖ´Â ´ÙÀç´Ù´ÉÇÑ µµ±¸ÀÔ´Ï´Ù. »ý¹°ÇÐÀû °úÁ¤À» ºÐÀÚ ¼öÁØ¿¡¼ ÀÌÇØÇÏ¸é ´Ù¾çÇÑ °úÇÐ ±â¼ú ºÐ¾ßÀÇ ¹ßÀüÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.
2021³â 9¿ù MDPI Àú³Î¿¡ ¹ßÇ¥µÈ ¿¬±¸ ³í¹®¿¡ µû¸£¸é, ¸»Ãʵ¿¸ÆÁúȯ(PAD) À¯º´·üÀº 3-12%·Î ÃßÁ¤µÇ¸ç, ¹Ì±¹°ú À¯·´¿¡¼ ¾à 2,700¸¸ ¸íÀÌ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
¸¸¼º Áúȯ¿¡´Â º¹ÀâÇÑ ºÐÀÚ °æ·Î°¡ °ü¿©ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ±¸Á¶»ý¹°ÇÐÀº »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÔÀ¸·Î½á ÀáÀçÀûÀÎ ¾à¹° Ç¥ÀûÀ» ½Äº°ÇÏ°í °ËÁõÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ±¸Á¶»ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ±â¼úÀº ÀáÀçÀûÀÎ ½Å¾à Ÿ°ÙÀ» ½Äº°ÇÏ°í Æ¯Á¤ Ä¡·áÁ¦¸¦ ¼³°èÇÏ´Â µ¥ ±â¿©ÇÕ´Ï´Ù. ¾Ï, ½Å°æ ÅðÇ༺ Áúȯ°ú °°Àº ¸¸¼º Áúȯ Áõ°¡´Â Ç¥Àû Ä¡·á¿Í °³ÀÎÈ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù.
Áøº¸¿¡µµ ºÒ±¸ÇÏ°í º¹ÀâÇÑ »ý¹°ÇÐÀû ½Ã½ºÅÛ¿¡ ´ëÇÑ ÀÌÇØ´Â ¿©ÀüÈ÷ ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. Ç¥Àû ´Ü¹éÁúÀÇ 3Â÷¿ø ±¸Á¶¿¡ ´ëÇÑ ÀÌÇØ°¡ ºÎÁ·Çϸé È¿°úÀûÀÎ ¾à¹° È常¦ ½Äº°ÇÏ°í ¼³°èÇÏ´Â µ¥ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ±× °á°ú, ÀǾàǰ °³¹ß ¼Óµµ°¡ ´À·ÁÁö°í È¿À²¼ºÀÌ ¶³¾îÁú ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ü¹éÁú ¸®°£µå »óÈ£ ÀÛ¿ëÀÇ ³·Àº ¿¹Ãø Á¤È®µµ¿Í »ý¹°ÇÐÀû ½Ã½ºÅÛÀÇ º¹À⼺°ú °°Àº ¿äÀεµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù.
±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ÇÁ·Î¼¼½º¿¡¼ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)ÀÇ ÅëÇÕÀº µ¥ÀÌÅÍ ºÐ¼®ÀÇ ¼Óµµ¿Í Á¤È®¼ºÀ» Çâ»ó½Ã۰í, AI ¾Ë°í¸®ÁòÀº »ý¹°ÇÐÀû µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ÀáÀçÀûÀÎ ½Å¾à °³¹ß Ç¥ÀûÀ» ½Äº°ÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù È¿À²ÀûÀÎ ½Å¾à °³¹ß ÆÄÀÌÇÁ¶óÀÎÀ» °³¹ßÇϰí Ä¡·á È¿°ú¸¦ Çâ»ó½ÃŰ°í ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Ä¡·á È¿°ú¸¦ °³¼±ÇÏ°í ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº ÀÌ ºÐ¾ßÀÇ ½Å¾à °³¹ßÀÇ È¿À²¼º, Á¤È®¼º ¹× Àü¹ÝÀûÀÎ ¼º°ø·üÀ» ´õ¿í Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.
±¸Á¶»ý¹°ÇÐÀ̳ª ºÐÀÚ ¸ðµ¨¸µ ±â¼ú¿¡´Â °í°¡ÀÇ Àåºñ¿Í ¼ÒÇÁÆ®¿þ¾î, ¼÷·ÃµÈ ÀηÂÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ÃÖ÷´Ü ±â¼ú°ú Ư¼ö Àåºñ¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ÷´Ü ¿¬±¸¼Ò¿Í Àü¹® ½Ã¼³À» ¼³¸³Çϰí À¯ÁöÇϱâ À§Çؼ´Â ¸·´ëÇÑ ¼³ºñÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ¼ÒÇÁÆ®¿þ¾î ¶óÀ̼±½º ¹× ÇØ¼®À» À§ÇÑ ¼÷·ÃµÈ Àη µî ½ÇÇè µ¥ÀÌÅÍ ºÐ¼®°ú °ü·ÃµÈ ºñ¿ëµµ Àüü Ãʱ⠺ñ¿ëÀÇ ÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ¿© ½ÃÀå ¼ö¿ä¸¦ ÀúÇØÇϰí ÀÖ½À´Ï´Ù.
»ý¸í°úÇÐ ºÐ¾ßÀÇ ¸¹Àº ¿¬±¸ ³ë·ÂÀº ¹é½Å °³¹ß, ¾à¹° Àç»ç¿ë, ¹ÙÀÌ·¯½º ±¸Á¶¿Í ±â´É ±Ô¸í µî Äڷγª °ü·Ã ¿¬±¸¿¡ ÁýÁߵƽÀ´Ï´Ù. ÀÌ·¯ÇÑ ÀÚ¿øÀÇ ÀçºÐ¹è´Â ±¸Á¶ »ý¹°ÇÐ, ºÐÀÚ ¸ðµ¨¸µ°ú °°Àº ºñ Äڷγª °ü·Ã ¿¬±¸ ºÐ¾ß¿¡µµ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. °æÁ¦Àû ºÒÈ®½Ç¼º°ú ÆÒµ¥¹Í ±â°£ µ¿¾ÈÀÇ ¿ì¼±¼øÀ§ º¯È·Î ÀÎÇØ ¿¬±¸ ÇÁ·ÎÁ§Æ® ÀÚ±Ý Á¶´Þ¿¡ ¾î·Á¿òÀ» °Þ¾ú½À´Ï´Ù. ¶ÇÇÑ, Äڷγª19¿¡ ´ëÇÑ Ä¡·á¹ý ¹ß°ßÀÌ ½Ã±ÞÇØÁö¸é¼ Ç×¹ÙÀÌ·¯½ºÁ¦ ¹ß°ß¿¡ ´ëÇÑ °ü½É°ú ÅõÀÚ°¡ Áõ°¡ÇÏ¿© ±¸Á¶»ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ºÐ¾ß¿¡µµ °£Á¢ÀûÀÎ ÇýÅÃÀ» °¡Á®¿Ô½À´Ï´Ù.
ÀüÀÚ Çö¹Ì°æ ºÎ¹®Àº À¯¸®ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀüÀÚ Çö¹Ì°æ ±â¼úÀº °íÇØ»óµµ¸¦ Á¦°øÇÏ¿© ¿¬±¸ÀÚµéÀÌ ºÐÀÚ ¼öÁØ, ½ÉÁö¾î ¿øÀÚ ¼öÁرîÁö ±¸Á¶¸¦ ½Ã°¢ÈÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀüÀÚ Çö¹Ì°æÀº ±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µÀÇ °·ÂÇÑ µµ±¸·Î, »ý¹°ÇÐÀû °úÁ¤°ú Áúº´ ¸ÞÄ¿´ÏÁòÀ» ÀÌÇØÇÏ°í ½Å¾à °³¹ß Ȱµ¿À» ÃËÁøÇÏ´Â µ¥ ÇʼöÀûÀÎ »ó¼¼ÇÑ ±¸Á¶ Á¤º¸¸¦ Á¦°øÇϸç, ÀüÀÚ Çö¹Ì°æ ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ÀÌ ºÐ¾ßÀÇ Á߿伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù.
½Å¾à °³¹ß ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ±â¼úÀº Áúº´ÀÇ ºÐÀÚ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇÏ°í »õ·Î¿î Ä¡·áÁ¦ÀÇ ¼³°è¸¦ ÃËÁøÇÔÀ¸·Î½á ½Å¾à °³¹ß¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ½Å¾à °³¹ß ÆÄÀÌÇÁ¶óÀÎÀ» º¸´Ù È¿À²ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀ¸·Î °£¼ÒÈÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¿Í ¹ßÀüÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷Àº ±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ µµ±¸¿¡ ´ëÇÑ ¼ö¿ä¿¡ Å©°Ô ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ °úÇÐ ¿¬±¸ ¹× »ý¸í °øÇп¡ ´ëÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀÚ±Ý Áö¿øÀº ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
À¯·´Àº Áö¼ÓÀûÀÎ ¹ßÀü, °øµ¿ ¿¬±¸ ¹× ÆÄÆ®³Ê½ÊÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ±¸Á¶ »ý¹°ÇÐ ¹× ºÐÀÚ ¸ðµ¨¸µ ±â¼ú ¿¬±¸¸¦ ÃËÁøÇÏ´Â µ¥ ÀÖ¾î Á¤ºÎ ÀÚ±Ý, ¹Î°£ ÅõÀÚ ¹× º¸Á¶±ÝÀÌ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. À¯·´ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â ´Ù½î½Ã½ºÅÛ(Dassault Systemes), ¾ÖÀÚÀÏ ºÐÀÚ(Agile Molecule), ¾Æ¼¿¶ó(Acellera Limited) µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚ±Ý Á¶´Þ °¡´É¼º°ú °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó À¯·´ ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Structural Biology & Molecular Modeling Market is accounted for $4.91 billion in 2023 and is expected to reach $15.85 billion by 2030 growing at a CAGR of 18.2% during the forecast period. Structural Biology and Molecular Modeling are two closely related fields that play a crucial role in understanding the structure and function of biological macromolecules at the molecular level. They are versatile tools with applications ranging from basic research to practical applications in medicine, agriculture, and industry. They provide a molecular-level understanding of biological processes, facilitating advancements in various scientific and technological fields.
According to the MDPI Journal research article published in September 2021, the prevalence of Peripheral Arterial Disease (PAD) is estimated to be 3-12%, affecting nearly 27 million people in America and Europe.
Chronic diseases often involve complex molecular pathways. Structural biology helps identify and validate potential drug targets by providing detailed information. Structural biology and molecular modeling contribute to the identification of potential drug targets and the design of specific therapeutics. The increasing prevalence of chronic diseases, such as cancer and neurodegenerative disorders, has fuelled the demand for targeted and personalized therapies.
Despite advancements, understanding of complex biological systems is still evolving. A limited understanding of the three-dimensional structures of target proteins can impede the identification and design of effective drug candidates. This can result in a slower and less efficient drug development process. Additionally, factors such as inaccuracy in predicting protein-ligand interactions and complexities of biological systems hampers the market growth.
The integration of artificial intelligence (AI) and machine learning (ML) in structural biology and molecular modeling processes enhances the speed and accuracy of data analysis. AI algorithms can analyze biological data to identify potential drug targets. It presents opportunities for the development of more efficient drug discovery pipelines, improving treatment efficacy and minimizing side effects. This integration further enhances the efficiency, accuracy, and overall success rate of drug discovery and development efforts in this field.
Structural biology and molecular modeling techniques often involve expensive equipment, software, and skilled personnel. They heavily rely on cutting-edge technologies and specialized equipment. Also, establishing & maintaining state-of-the-art laboratories and specialized facilities requires significant capital investment. Additionally, the costs associated with analyzing experimental data, including software licenses and skilled personnel for interpretation contribute to the overall initial expenses thereby hampering the market demand.
Many research efforts in the life sciences were redirected toward covid related studies, including vaccine development, drug repurposing, and understanding the virus's structure and function. This redirection of resources has impacted non-covid-related research areas, including structural biology and molecular modeling. Economic uncertainties and shifting priorities during the pandemic have led to funding challenges for research projects. Further, the urgency of finding treatments for covid has spurred increased interest and investment in antiviral drug discovery, which indirectly benefitted the structural biology and molecular modeling sector.
The electron microscopy segment is estimated to have a lucrative growth. Electron microscopy technique offers high resolution and allows researchers to visualize structures at the molecular and even atomic levels. It is a powerful tool in structural biology and molecular modeling, providing detailed structural information that is crucial for understanding biological processes, disease mechanisms, and facilitating drug discovery efforts. The continuous advancements in EM technology further contribute to its significance in the field.
The drug discovery segment is anticipated to witness the highest CAGR growth during the forecast period. Structural biology and molecular modeling play crucial roles in drug discovery by providing valuable insights into the molecular mechanisms of diseases and facilitating the design of novel therapeutic agents. These techniques help streamline the drug discovery pipeline, making it more efficient and cost-effective.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing investments and advances in research and development. The pharmaceutical and biotechnology industries in the Asia Pacific region are likely to contribute significantly to the demand for structural biology and molecular modeling tools. Further, government initiatives and funding for scientific research and biotechnology can positively influence the market.
Europe is projected to have the highest CAGR over the forecast period, owing to the continuous advancements, collaborations and partnerships. Government funding, private investments and grants play a significant role in advancing research in structural biology and molecular modeling in the region. Some prominent players in the European market include Dassault Systemes, Agile Molecule and Acellera Limited. Further, funding availability and growing emphasis on personalized medicine can impact the growth of the market in europe.
Some of the key players profiled in the Structural Biology & Molecular Modeling Market include Acellera Limited, Thermo Fisher Scientific Inc, Illumina Inc., Horiba, Chemical Computing Group ULC, Bruker Daltonics, Agilent Technologies Inc., Charles River Laboratories, Dassault Systemes, Biomax Informatics AG, Agile Molecule and Bioinformatic LLC.
In November 2023, The Accelra Company released a new version of ACEMD, Accela's molecular dynamics simulation software. ACEMD is a highly optimized molecular dynamics (MD) engine that runs on NVIDIA GPUs. It's free for non-profit research, but commercial licenses are available for other uses.
In September 2023, Thermo Scientific launched the new Hydra Bio Plasma-Focused Ion Beam (Plasma-FIB) for cell biologists seeking simplified workflows while undertaking volume electron microscopy for cryo or resin-embedded samples. The Hydra Bio Plasma-FIB is a versatile, multi-application instrument that supports volume electron microscopy and sample preparation for the cryo-electron tomography workflow.